GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (LIM:JNJ) » Definitions » Sale Of Investment

Johnson & Johnson (LIM:JNJ) Sale Of Investment : $5,775 Mil (TTM As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Johnson & Johnson Sale Of Investment?

Johnson & Johnson's sale of investment for the three months ended in Sep. 2024 was $-964 Mil. It means Johnson & Johnson gained $-964 Mil from selling investments. Johnson & Johnson's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was $5,775 Mil.

Compared with last quarter ($2,157 Mil in Jun. 2024 ), Johnson & Johnson gained less money from selling investments in Sep. 2024 ($-964 Mil).

Johnson & Johnson Sale Of Investment Historical Data

The historical data trend for Johnson & Johnson's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Sale Of Investment Chart

Johnson & Johnson Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,387.00 12,137.00 25,006.00 41,609.00 19,390.00

Johnson & Johnson Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,910.00 3,603.00 979.00 2,157.00 -964.00

Johnson & Johnson Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5,775 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Johnson & Johnson Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (LIM:JNJ) » Definitions » Sale Of Investment
Comparable Companies
ABBV MRK PFE AMGN GILD BMY BIIB OGN AMRN SCLX LLY OCSE:NOVO B XSWX:ROG LSE:AZN XSWX:NOVN XPAR:SAN TSE:4519 LSE:GSK TSE:4568 SHSE:600276
Traded in Other Exchanges
JNJ:USA JNJ:Mexico JNJ_KZ:Kazakhstan 1JNJ:Italy JNJd:UK JNJ0:Germany JNJ:Germany JNJ:Germany JNJ:Germany JNJ:Germany JNJ:Canada JNJB34:Brazil JNJ:Bulgaria JNJ:Austria JNJ:Argentina
Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Website
https://www.jnj.com
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.